Resources

Article

January 16, 2025

Key Considerations for Development and Commercialization of Drug Device Combination Products in Rare Diseases

Article

January 09, 2025

Strategic CDMO Growth in a Dynamic Market

Article

January 06, 2025

The Use of Autoinjectors for Autoimmune Diseases: Advancements, Benefits, and Considerations

Article

December 16, 2024

New Product Introduction and Technical Transfer in a High-Potency Facility

Article

November 26, 2024

Pediatric Drug Development: The Liquid Challenge

Article

November 25, 2024

The High Potent Pathway

Article

November 04, 2024

CPHI Supplement with PCI Pharma Services: Your trusted partner for scalable CDMO solutions throughout the product lifecycle.

Article

October 24, 2024

Clinical Trial Kit Design & Forecasting for the Pharmaceutical and Biopharmaceutical Industry

Article

October 23, 2024

Shawn Murtough shares insights on key industry topics and GMP regulatory changes over the years.

Article

October 09, 2024

The Multifaceted Future of Pharma - Conquering the Undruggable.

Article

October 08, 2024

Advanced Drug Delivery Solutions Showcase

Article

September 16, 2024

The ESG Journey: Establishing Processes and Driving Results

talkfuture@pci.com

Always growing and continually advancing, we support you from early-stage development through commercialization and beyond, and with 7000+ people in 30 global GMP facilities, we are always near.